Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by mitch0frenchon Aug 16, 2017 12:07pm
202 Views
Post# 26587817

RE:people say i'm negative but i think i;m realistic and for

RE:people say i'm negative but i think i;m realistic and forI will use your knowledge and ask your opinion on one exemple:  Intermune Cie (perfenidone )

1-----for the year ended 2013,they loose 198 million US
2-----q1/2014 they loose 53 millions US
3-----q2/2014 -------Roche buy them for 8 Billions

They never produce themselve the products ,they do not have producing facility at that time.

Knowing that the FDA accept to discard Perfenidone from the futur PBI trial and seeing the numbers here , I can`t logically understand why PLI is hammered like that , they deserved more respect for what they already achieved .

 PLI feed the FDA with there request,trying to be realistic , it is because they work on the case right now ,if not they will not be asking more details .

To end this ,you try to be realistic and i can't say your not , but we can also be logic ,and actually the market is not logic with the position of PLI ,when we try to make comparison with other pharma.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse